Table 1.
Number of clinical samples in each age group.
| Variable | Number of samples (%) | Age group | |||
|---|---|---|---|---|---|
| < 6 years | 6–17 years | 18–64 years | ≥ 65 years | ||
| Samples collected | 2,992 (100%) | 124 (100%) | 88 (100%) | 1,191 (100%) | 1,589 (100%) |
| Valid CDC RT‒PCR assay resultsa | 2,949a (98.6%) | 123 (99.2%) | 88 (100%) | 1,178 (98.9%) | 1,560 (98.2%) |
| Outpatientb | 2,267 (76.9%) | 95 (77.2%) | 68 (77.3%) | 1,006 (85.4%) | 1,098 (70.4%) |
| Negative for SARS-CoV-2/Flu/RSV by two CDC RT‒PCR assays | 2,155 (73.1%) | 82 (66.7%) | 65 (73.9%) | 786 (66.7%) | 1,222 (78.3%) |
| Tested by FilmArray | 928 (43.1%) | 43 (52.4%) | 31 (47.7%) | 444 (56.5%) | 410 (33.6%) |
| Tested positive for pathogens other than SARS-CoV-2/Flu/RSV by FilmArrayc | 204 (22.0%) | 29 (67.4%) | 15 (48.4%) | 118 (26.6%) | 42 (10.2%) |
aNasopharyngeal swabs, n = 2,522; nasal swabs, n = 427.
bThe remaining samples were collected from hospitalized inpatients.
cAll the other samples tested negative, and there were no invalid results.